Skip to content

Contribution of genetic factors to recurrent vulvovaginal candidiasis

Contribution of genetic factors to recurrent vulvovaginal candidiasis - Genetic factors in RVVC

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33313
Enrollment
200
Registered
2009-08-03
Start date
2010-06-01
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent vaginal candida infection Recurrent vulvovaginal candidiasis

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: •Minimum age 18 years •At least 3 episodes of symptomatic vulvovaginal candidiasis within the last year •At least one of these episodes needs to be confirmed with a positive culture for Candida •Western European descent

Exclusion criteria

Exclusion criteria: •Diabetes mellitus •HIV or other iknown mmune disorder •Use of immunosuppressive drugs or chemotherapy •Episodes preceded by the use of antibiotics

Design outcomes

Primary

MeasureTime frame
Presence of polymorphisms in the genes of the innate immune system, that are involved in the host defense against vulvovaginal Candida infections.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)